Mode
Home
Research
Clinical Trials Drug Pipeline Weekly Digests
Reference
Conditions Medications
Community
Questions
Text Size
Log in / Sign up
N/A N=327 Randomized Double-blind Treatment

Kids Safe and Smokefree (KiSS)

Second Hand Tobacco Smoke · Nicotine Dependence

Bottom Line

View on ClinicalTrials.gov: NCT01745393 ↗
Enrolled (actual)
327
Serious AEs
0.0%
Results posted
Aug 2018
Primary outcome: Primary: Child Urine Cotinine — 0.892; 0.891 log transformed ng/mL

Study Design & Population

Study type
Interventional
Phase
N/A
Interventions
Clinic Quality Improvement + Behavioral Counseling (Behavioral); Clinic Quality Improvement + Attention Control (Behavioral)
Age
Adult, Older Adult · 18+ yrs
Sex
All
Sponsor
Temple University
Primary completion
Jun 2016

Outcome Measures

OutcomeResultp-value
PRIMARY
Child Urine Cotinine		 0.892; 0.891 —
PRIMARY
Parent-reported Second-hand Smoke Exposure in Cigarettes Per Day From All Sources		 3.8; 3.04 —
SECONDARY
Parent-reported Cotinine-verified 7-day Point Prevalence Abstinence		 20; 10 —

Summary

The study's primary aim is to test the hypothesis that an intervention integrating pediatric clinic-level quality improvement with home-level behavioral counseling (CQI+BC) will result in greater reductions in child cotinine (a biomarker of secondhand smoke exposure) and reported cigarettes exposed/day than a clinic-level quality improvement plus attention control intervention (CQI+A). A secondary aim is to test the hypothesis that relative to CQI+A, CQI+BC will result in higher cotinine-verified, 7-day point prevalence quit rate among parents.

Eligibility Criteria

Inclusion Criteria

  • at least 18 years of age
  • English-speaking
  • parent or legal guardian of child under 11 years old who lives with him/her
  • daily smoker

Exclusion Criteria

  • non-nicotine drug dependence
  • psychiatric disturbance (bipolar, schizophrenia, psychosis)
  • pregnant
  • inadequate health literacy
View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT01745393). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.

Back to search